University of Toronto
Researchers from Canada, Austria and Germany detail new studies and findings in the area of cardiology
Published in Managed Care Business Week, June 20th, 2006
Study 1: Coronary restenosis is prevented by the tyrosine kinase inhibitor (TKI) SU11218.
According to a study from Canada, "The aim of this study was to delineate the temporal profile of adventitial microvessel (Ad-MV) formation after stenting, its relationship to arterial wall hypoxia, and the effects of a TKI, SU11218, on Ad-MV and in-stent intimal hyperplasia (IH)."
"Adventitial microvessels have been reported after arterial injury; however, the underlying stimulus for this response and its relationship to IH is unknown," wrote .N. Cheema and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
More Articles from Managed Care Business Week
- Collaborations
BenefitPoint and Symetra team up to enhance employee benefit choices - Medicare
America's Health Insurance Plans applauds CMS leadership in transparency of health care information - Aachen University
Platelet-monocyte aggregate formation is affected by phosphodiesterase III inhibition - Aarhus University Hospital
Hypocaloric diet and physical activity improved insulin sensitivity and inflammation obese - Addenbrookes Hospital, Cambridge
Studies from Addenbrookes Hospital, Cambridge highlight latest findings - All India Institute of Medical Sciences, New Delhi
Heterogeneous phenotypes of insulin resistance can identify metabolic syndrome in youth - More from this issue of Managed Care Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
